Target Price | $169.14 |
Price | $153.73 |
Potential |
10.03%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target DaVita HealthCare Partners 2026 .
The average DaVita HealthCare Partners target price is $169.14.
This is
10.03%
register free of charge
$186.00
20.99%
register free of charge
$145.00
5.68%
register free of charge
|
|
A rating was issued by 12 analysts: 1 Analysts recommend DaVita HealthCare Partners to buy, 10 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the DaVita HealthCare Partners stock has an average upside potential 2026 of
10.03%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 12.82 | 13.49 |
5.56% | 5.27% | |
EBITDA Margin | 20.90% | 20.61% |
8.14% | 1.40% | |
Net Margin | 6.74% | 6.61% |
36.99% | 1.98% |
7 Analysts have issued a sales forecast DaVita HealthCare Partners 2025 . The average DaVita HealthCare Partners sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an DaVita HealthCare Partners EBITDA forecast 2025. The average DaVita HealthCare Partners EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 DaVita HealthCare Partners Analysts have issued a net profit forecast 2025. The average DaVita HealthCare Partners net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 10.73 | 11.08 |
44.61% | 3.26% | |
P/E | 13.88 | |
EV/Sales | 1.88 |
4 Analysts have issued a DaVita HealthCare Partners forecast for earnings per share. The average DaVita HealthCare Partners EPS is
This results in the following potential growth metrics and future valuations:
DaVita HealthCare Partners...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Aug 20 2024 |
Analyst Rating | Date |
---|---|
Locked
Barclays:
Locked
➜
Locked
|
Feb 18 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Oct 31 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 07 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.